Found: 12
Select item for more details and to access through your institution.
A Novel Prophylaxis Strategy Using Liposomal Vaccine Adjuvant CAF09b Protects against Influenza Virus Disease.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 3, p. 1850, doi. 10.3390/ijms23031850
- By:
- Publication type:
- Article
Induction of Cytotoxic T-Lymphocyte Responses Upon Subcutaneous Administration of a Subunit Vaccine Adjuvanted With an Emulsion Containing the Toll-Like Receptor 3 Ligand Poly(I:C).
- Published in:
- Frontiers in Immunology, 2018, p. 1, doi. 10.3389/fimmu.2018.00898
- By:
- Publication type:
- Article
Evaluation of the Sublingual Route for Administration of Influenza H5N1 Virosomes in Combination with the Bacterial Second Messenger c-di-GMP.
- Published in:
- PLoS ONE, 2011, v. 6, n. 11, p. 1, doi. 10.1371/journal.pone.0026973
- By:
- Publication type:
- Article
Reply to Sambhara.
- Published in:
- 2013
- By:
- Publication type:
- Letter
A(H1N1)pdm09 Vaccination of Health Care Workers: Improved Immune Responses in Low Responders Following Revaccination.
- Published in:
- Journal of Infectious Diseases, 2012, v. 206, n. 11, p. 1660, doi. 10.1093/infdis/jis589
- By:
- Publication type:
- Article
Modulation of immune responses using adjuvants to facilitate therapeutic vaccination.
- Published in:
- Immunological Reviews, 2020, v. 296, n. 1, p. 169, doi. 10.1111/imr.12889
- By:
- Publication type:
- Article
Tailoring T<sub>fh</sub> profiles enhances antibody persistence to a clade C HIV-1 vaccine in rhesus macaques.
- Published in:
- eLife, 2024, p. 1, doi. 10.7554/eLife.89395
- By:
- Publication type:
- Article
SARS-CoV-2 spike HexaPro formulated in aluminium hydroxide and administered in an accelerated vaccination schedule partially protects Syrian Hamsters against viral challenge despite low neutralizing antibody responses.
- Published in:
- Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.941281
- By:
- Publication type:
- Article
Vaccine Adjuvants Differentially Affect Kinetics of Antibody and Germinal Center Responses.
- Published in:
- Frontiers in Immunology, 2020, v. 11, p. N.PAG, doi. 10.3389/fimmu.2020.579761
- By:
- Publication type:
- Article
Toll like-receptor agonist Pam3Cys modulates the immunogenicity of liposomes containing the tuberculosis vaccine candidate H56.
- Published in:
- Medical Microbiology & Immunology, 2020, v. 209, n. 2, p. 163, doi. 10.1007/s00430-020-00657-3
- By:
- Publication type:
- Article
Sublingual Boosting with a Novel Mucoadhesive Thermogelling Hydrogel Following Parenteral CAF01 Priming as a Strategy Against Chlamydia trachomatis (Adv. Healthcare Mater. 11/2022).
- Published in:
- Advanced Healthcare Materials, 2022, v. 11, n. 11, p. 1, doi. 10.1002/adhm.202270055
- By:
- Publication type:
- Article
Sublingual Boosting with a Novel Mucoadhesive Thermogelling Hydrogel Following Parenteral CAF01 Priming as a Strategy Against Chlamydia trachomatis.
- Published in:
- Advanced Healthcare Materials, 2022, v. 11, n. 11, p. 1, doi. 10.1002/adhm.202102508
- By:
- Publication type:
- Article